Entity Details

Primary name CACP_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP43155
EntryNameCACP_HUMAN
FullNameCarnitine O-acetyltransferase
TaxID9606
Evidenceevidence at protein level
Length626
SequenceStatuscomplete
DateCreated1995-11-01
DateModified2021-06-02

Ontological Relatives

GenesCRAT

GO terms

Show/Hide Table
GOName
GO:0003997 acyl-CoA oxidase activity
GO:0004092 carnitine O-acetyltransferase activity
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0005777 peroxisome
GO:0005782 peroxisomal matrix
GO:0005783 endoplasmic reticulum
GO:0005829 cytosol
GO:0008104 protein localization
GO:0008458 carnitine O-octanoyltransferase activity
GO:0019254 carnitine metabolic process, CoA-linked
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
GO:0046459 short-chain fatty acid metabolic process
GO:0051791 medium-chain fatty acid metabolic process

Subcellular Location

Show/Hide Table
Subcellular Location
Endoplasmic reticulum
Mitochondrion
Mitochondrion inner membrane
Peroxisome

Domains

Show/Hide Table
DomainNameCategoryType
IPR000542 Acyltransferase ChoActase/COT/CPTFamilyFamily
IPR039551 Choline/carnitine acyltransferase domainDomainDomain
IPR042231 Choline/Carnitine o-acyltransferase, domain 2FamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617917 OMIMNeurodegeneration with brain iron accumulation 8 (NBIA8)A neurodegenerative disorder associated with iron accumulation, primarily in the basal ganglia. Disease onset is in early childhood. Clinical features include speech delay, progressive cerebellar ataxia, unbalanced gait, and loss of ambulation. NBIA8 transmission pattern is consistent with autosomal recessive inheritance. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00583 LevocarnitineDrugbanksmall molecule
DB01992 Coenzyme ADrugbanksmall molecule
DB02648 (3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-AmmoniumDrugbanksmall molecule